Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Antisense oligonucleotides targeted to human CDC45










Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.








 
 
  Recently Added Patents
Pipette device
Managing personal information on a network
Defensin polynucleotides and methods of use
System and method for associating financial transaction data with user's project data
Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo- -1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing t
System and method for managing content on a network interface
TV wall mount
  Randomly Featured Patents
Foundation crack sealer and method of use
Methods and apparatus for processing digital signals by allocation of subband signals and recording medium therefor
Movement limiting device for bridge bearing
Amusement park ride
Technique for optimizing cut-through for broadcast and multi-cast packets in a multi-port bridge for a local area network
Cannula and sizing and insertion method
Signature gripper and delivery device
Crape-myrtle named Purple Queen
Silver halide photographic light-sensitive material
Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation